Skip to main content
Erschienen in: Optical and Quantum Electronics 3/2024

01.03.2024

Optical imaging medical diagnosis and analysis of drug treatment for endometriosis and the impact of serum VEGF and MMP-9

verfasst von: Chunyan Wang, Qingtao Li

Erschienen in: Optical and Quantum Electronics | Ausgabe 3/2024

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

With the continuous development of biomedical imaging technologies such as computed tomography, laser scanning confocal microscopy and ultrasonic imaging, biomedical imaging plays an increasingly obvious role in this field and becomes an important means of biological research and clinical medicine diagnosis and treatment. The purpose of the study was to analyze the application of optical imaging in the medical diagnosis of endometriosis, and to explore the effect of drug therapy on the disease. The changes in serum VEGF and MMP-9 levels in endometriosis and their potential clinical significance were also investigated. This study mainly analyzes and compares the efficacy of Sanjie Zhentong capsule combined with norethisterone tablets in the treatment of endometriosis and the effect on serum VEGF, MMP-9 and sICAM-1 levels. The total effective rate of patients in group B after this combined intervention was 91.07% (51/56), which was more significant compared with 75.0% (39/52) of patients in group A. The curative effect of the included patients in the two groups was significant. After intervention, the VEGF (193.62 ± 45.45), MMP-9 (197.34 ± 22.63), and sICAM-1 (323.58 ± 8.52) indexes of patients in group A were compared with those of patients in group B (121.45 ± 34.78), MMP-9 ( 128.56 ± 15.86), sICAM-1 (264.87 ± 7.62). The results show that it has high safety and fewer clinical adverse symptoms. Through optical imaging technology, patients with endometriosis are accurately diagnosed and the extent and location of their lesions are observed, helping doctors to provide accurate diagnosis and treatment recommendations.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
Zurück zum Zitat Amini, L., Shami, M., Chegini, R.: The relationship between serum levels of oxidative stress biomarkers and dysmenorrhea, dyspareunia and pelvic pain in women with endometriosis. Iran J. Nurs. 6(126), 90–92 (2020) Amini, L., Shami, M., Chegini, R.: The relationship between serum levels of oxidative stress biomarkers and dysmenorrhea, dyspareunia and pelvic pain in women with endometriosis. Iran J. Nurs. 6(126), 90–92 (2020)
Zurück zum Zitat Arumugam, K.: Serum prolactin levels in infertile patients with endometriosis. Malays. J. Pathol. 13(1), 43–45 (2021) Arumugam, K.: Serum prolactin levels in infertile patients with endometriosis. Malays. J. Pathol. 13(1), 43–45 (2021)
Zurück zum Zitat Barcz, E., Kamiński, P., Marianowski, L.: Serum VEGF (vascular endothelial growth factor) concentration in patients with endometriosis. Ginekol. Pol. 71(9), 993–1000 (2020) Barcz, E., Kamiński, P., Marianowski, L.: Serum VEGF (vascular endothelial growth factor) concentration in patients with endometriosis. Ginekol. Pol. 71(9), 993–1000 (2020)
Zurück zum Zitat Cahill, D.J., et al.: Effect of progestogen therapy on follicular development, related hormone concentrations and fertilization in vitro in unstimulated cycles and unexplained and endometriosis-associated infertility. Hum. Reprod. (Oxford, England) 65(23), 12–15 (2018) Cahill, D.J., et al.: Effect of progestogen therapy on follicular development, related hormone concentrations and fertilization in vitro in unstimulated cycles and unexplained and endometriosis-associated infertility. Hum. Reprod. (Oxford, England) 65(23), 12–15 (2018)
Zurück zum Zitat Chartier, M.: Antiovulatory drugs in the treatment of endometriosis. Netter A 32(34), 52–55 (2020) Chartier, M.: Antiovulatory drugs in the treatment of endometriosis. Netter A 32(34), 52–55 (2020)
Zurück zum Zitat Essam, E.E.-D.R.: Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 20(21), 1–5 (2018) Essam, E.E.-D.R.: Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 20(21), 1–5 (2018)
Zurück zum Zitat Ferrero, S., Gillott, D.J., Anserini, P., et al.: Methodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Int. J. Fertility Steril. 19(1), 220–221 (2019) Ferrero, S., Gillott, D.J., Anserini, P., et al.: Methodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Int. J. Fertility Steril. 19(1), 220–221 (2019)
Zurück zum Zitat Ferrero, S., Venturini, P.L., Gillott, D.J., et al.: Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial. Reprod. Biol. Endocrinol. 9(1), 88 (2021)CrossRef Ferrero, S., Venturini, P.L., Gillott, D.J., et al.: Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial. Reprod. Biol. Endocrinol. 9(1), 88 (2021)CrossRef
Zurück zum Zitat Fu, C., Lang, J.: Serum soluble E-cadherin level in patients with endometriosis. Chin. Med. Sci. J. 17(2), 121–123 (2021) Fu, C., Lang, J.: Serum soluble E-cadherin level in patients with endometriosis. Chin. Med. Sci. J. 17(2), 121–123 (2021)
Zurück zum Zitat Gagne, D., Page, M., Robitaille, G., et al.: Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum. Reprod. 6(67), 2–5 (2021) Gagne, D., Page, M., Robitaille, G., et al.: Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum. Reprod. 6(67), 2–5 (2021)
Zurück zum Zitat Gagné, D., Pagé, M., Robitaille, G., et al.: Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum. Reprod. 18(8), 1674–1680 (2019)CrossRef Gagné, D., Pagé, M., Robitaille, G., et al.: Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum. Reprod. 18(8), 1674–1680 (2019)CrossRef
Zurück zum Zitat Gosselin, D., Gagné, D., Pagé, M., et al.: Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum. Reprod. 60(54), 12–19 (2018) Gosselin, D., Gagné, D., Pagé, M., et al.: Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum. Reprod. 60(54), 12–19 (2018)
Zurück zum Zitat Grandi, G., Mueller, M., Bersinger, N., et al.: Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells. Am. J. Reprod. Immunol. 66(54), 152–154 (2016) Grandi, G., Mueller, M., Bersinger, N., et al.: Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells. Am. J. Reprod. Immunol. 66(54), 152–154 (2016)
Zurück zum Zitat Kianpour, M., Nematbakhsh, M., Ahmadi, S.M., et al.: Serum and peritoneal fluid levels of vascular endothelial growth factor in women with endometriosis. Int. J. Fertility Steril. 7(2), 96–99 (2018) Kianpour, M., Nematbakhsh, M., Ahmadi, S.M., et al.: Serum and peritoneal fluid levels of vascular endothelial growth factor in women with endometriosis. Int. J. Fertility Steril. 7(2), 96–99 (2018)
Zurück zum Zitat Qi-Gu, L.I., Pharmacy, D.O.: Clinical study on compound norethindrone tablet combined with metformin in the treatment of polycystic ovary syndrome. Med. Recapitulate 40(43), 82–85 (2018) Qi-Gu, L.I., Pharmacy, D.O.: Clinical study on compound norethindrone tablet combined with metformin in the treatment of polycystic ovary syndrome. Med. Recapitulate 40(43), 82–85 (2018)
Zurück zum Zitat Ravn, P., Bergqvist, A., Hansen, M.A., et al.: Treatment of endometriosis with the luteinizing hormone-releasing hormone agonist nafarelin. Effect on bone turnover and bone mass. Menopause J. North Am. Menopause Soc. 1(1), 11–17 (2021) Ravn, P., Bergqvist, A., Hansen, M.A., et al.: Treatment of endometriosis with the luteinizing hormone-releasing hormone agonist nafarelin. Effect on bone turnover and bone mass. Menopause J. North Am. Menopause Soc. 1(1), 11–17 (2021)
Zurück zum Zitat Sozzi, F., Morotti, M.: Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment. Eur. J. Obstet. Gynecol. Reprod. Biol. Int. J. 183(44), 188–192 (2018) Sozzi, F., Morotti, M.: Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment. Eur. J. Obstet. Gynecol. Reprod. Biol. Int. J. 183(44), 188–192 (2018)
Zurück zum Zitat Taniguchi, F., Enatsu, A., Ikebuchi, A., et al.: Efficacy of norethisterone in patients with ovarian endometrioma. Yonago Acta Medica 60(3), 182–185 (2017)CrossRefPubMedPubMedCentral Taniguchi, F., Enatsu, A., Ikebuchi, A., et al.: Efficacy of norethisterone in patients with ovarian endometrioma. Yonago Acta Medica 60(3), 182–185 (2017)CrossRefPubMedPubMedCentral
Zurück zum Zitat Yang, W.M.: Influence of mifepristone tablets on recurrence and serum VEGF of endometriosis patients after operation. J. Qiqihar Univ. Med. 4(32), 142–145 (2018) Yang, W.M.: Influence of mifepristone tablets on recurrence and serum VEGF of endometriosis patients after operation. J. Qiqihar Univ. Med. 4(32), 142–145 (2018)
Zurück zum Zitat Zhang, Q., Teng, H., Yuli, H.U.: Effects of leuprolide acetate microspheres combined with laparoscopy on serum TIMP-1 MMP-9 levels and conception rate in patients with endometriosis. Hebei Med. 3(32), 184–185 (2019) Zhang, Q., Teng, H., Yuli, H.U.: Effects of leuprolide acetate microspheres combined with laparoscopy on serum TIMP-1 MMP-9 levels and conception rate in patients with endometriosis. Hebei Med. 3(32), 184–185 (2019)
Metadaten
Titel
Optical imaging medical diagnosis and analysis of drug treatment for endometriosis and the impact of serum VEGF and MMP-9
verfasst von
Chunyan Wang
Qingtao Li
Publikationsdatum
01.03.2024
Verlag
Springer US
Erschienen in
Optical and Quantum Electronics / Ausgabe 3/2024
Print ISSN: 0306-8919
Elektronische ISSN: 1572-817X
DOI
https://doi.org/10.1007/s11082-023-06159-9

Weitere Artikel der Ausgabe 3/2024

Optical and Quantum Electronics 3/2024 Zur Ausgabe

Neuer Inhalt